Q&A

Expert Q&A
Deya Jourdy
Expert Q&A
08/18/2024
In this interview, Deya N. Jourdy, MD, talks about the clinical features, prevalence, diagnosis, and treatment for nasal polyps, including what surgical options are available for patients.
08/18/2024
expert Q&A
expert Q&A
08/12/2024
Margaret A. Lampe, RN, MPH
In this expert Q&A, Margaret A. Lampe, RN, MsC, discusses the elimination of perinatal HIV transmission, elimination goals set out by the CDC, next steps for research, and more.
08/12/2024
EXPERT Q&A
EXPERT Q&A
07/17/2024
In this Q&A, Brittany A. Davidson, MD, discusses navigating goals-of-care conversations in gynecologic oncology, including how to identify patients at high risk of death who might benefit from a timely...
07/17/2024
Expert Q&A
Expert Q&A
06/23/2024
Elmar A. Joura, MD
In this interview, Elmar Joura, MD, answers questions about the long-term follow-up data on sustained immunogenicity and safety for the 9-valent human papillomavirus (HPV) vaccine, including indications,...
06/23/2024
Expert Q&A
jacob
Expert Q&A
06/09/2024
In this interview, Jacob C. Jentzer, MD, assistant professor of medicine in the Department of Cardiovascular Medicine at the Mayo Clinic in Rochester, Minnesota discusses the implications of his study and...
06/09/2024
Expert Q&A
Stephanie Blank, MD
Expert Q&A
06/04/2024
Stephanie Blank, MD, answers questions about the session she hosted at The Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women's Cancer titled “The Future is Now: Determining the Fate of...
06/04/2024
Conference Coverage
Conference Coverage
06/03/2024
Yuriko Fukuta, MD, PhD
Yuriko Fukuta, MD, PhD, discusses her research team's study, which evaluated the risk factors associated with post-COVID conditions. She presented her findings at IDWeek 2023 in Boston, MA.
06/03/2024
expert Q&A
expert Q&A
05/31/2024

Joseph Magagnoli, MS

Joseph Magagnoli, MS
Acetylcholinesterase inhibitors are frequently used in the treatment of Alzheimer disease due to their anti-inflammatory effects. But what is the potential of this class of medications to also impact the...
05/31/2024
Expert Q&A
Expert Q&A
05/11/2024
In this Q and A, Chief Investigator of the EMPA-KIDNEY trial, William Herrington, MA, MBBS, MD, answers questions about the results of the trial, including the effects of the SGLT2 inhibitor, empagliflozin,...
05/11/2024
expert Q&A
expert Q&A
05/02/2024
Melissa E. Badowski, PharmD, MPH
In this expert interview, Melissa E. Badowski, PharmD, MPH, provides an overview of her presentation at IDWeek 2023 titled, "Guideline Adherence to Hepatitis B Virus Screening and Vaccination in Patients...
05/02/2024